Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

795 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hypertension severity, apparent treatment resistant hypertension and hyperuricemia in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study.
Tanner RM, Chaudary N, Colantonio LD, Merriman TR, Reynolds RJ, Bridges SL, Cushman M, Saag K, Limdi N, Muntner P, Howard G, Irvin MR. Tanner RM, et al. Among authors: muntner p. J Hypertens. 2023 Jun 1;41(6):1033-1039. doi: 10.1097/HJH.0000000000003425. Epub 2023 Apr 4. J Hypertens. 2023. PMID: 37016935
Recurrent Atherosclerotic Cardiovascular Disease Events Potentially Prevented with Guideline-Recommended Cholesterol-Lowering Therapy following Myocardial Infarction.
Sakhuja S, Bittner VA, Brown TM, Farkouh ME, Levitan EB, Safford MM, Woodward M, Chen L, Sun R, Dhalwani N, Jones J, Kalich B, Exter J, Muntner P, Rosenson RS, Colantonio LD. Sakhuja S, et al. Among authors: muntner p. Cardiovasc Drugs Ther. 2023 Apr 13. doi: 10.1007/s10557-023-07452-1. Online ahead of print. Cardiovasc Drugs Ther. 2023. PMID: 37052867
Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline.
Alanaeme CJ, Bittner V, Brown TM, Colantonio LD, Dhalwani N, Jones J, Kalich B, Exter J, Jackson EA, Levitan EB, Poudel B, Wang Z, Woodward M, Muntner P, Rosenson RS. Alanaeme CJ, et al. Among authors: muntner p. Am Heart J Plus. 2022 Sep;21:100201. doi: 10.1016/j.ahjo.2022.100201. Epub 2022 Aug 27. Am Heart J Plus. 2022. PMID: 37168932 Free PMC article.
Diabetes, gaps in care coordination, and preventable adverse events.
Colvin CL, Akinyelure OP, Rajan M, Safford MM, Carson AP, Muntner P, Colantonio LD, Kern LM. Colvin CL, et al. Among authors: muntner p. Am J Manag Care. 2023 Jun 1;29(6):e162-e168. doi: 10.37765/ajmc.2023.89374. Am J Manag Care. 2023. PMID: 37341980 Free article.
Requirements for design and function of blood pressure measuring devices used for the management of hypertension: Consensus Statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability and STRIDE BP.
Stergiou GS, Parati G, Kollias A, Schutte AE, Asayama K, Asmar R, Bilo G, de la Sierra A, Dolan E, Filipovsky J, Head G, Kario K, Kyriakoulis KG, Mancia G, Manios E, Menti A, McManus RJ, Mihailidou AS, Muntner P, Niiranen T, Ohkubo T, Omboni S, Protogerou A, Saladini F, Sharman J, Shennan A, Shimbo D, Topouchian J, Wang J, O'Brien E, Palatini P. Stergiou GS, et al. Among authors: muntner p. J Hypertens. 2023 Dec 1;41(12):2088-2094. doi: 10.1097/HJH.0000000000003482. Epub 2023 Jun 9. J Hypertens. 2023. PMID: 37303225
Race differences in ambulatory blood pressure monitoring parameters.
Sakhuja S, Jaeger BC, Yano Y, Shimbo D, Lewis CE, Clark Iii D, Tajeu GS, Hardy ST, Allen NB, Shikany JM, Schwartz JE, Viera AJ, Muntner P. Sakhuja S, et al. Among authors: muntner p. Blood Press Monit. 2024 Feb 1;29(1):23-30. doi: 10.1097/MBP.0000000000000680. Epub 2023 Sep 21. Blood Press Monit. 2024. PMID: 37889596
795 results